Energy Efficiency, GHG Emissions, Industrial - April 3, 2025
Roche’s Emission Targets Verified by SBTi
Biotech company Roche reached a significant milestone in its climate change efforts by receiving Science Based Targets initiative (SBTi) validation of its net-zero targets.
The company plans to achieve net-zero GHG emissions in its own operations and in its value chain across Scopes 1, 2 and 3 by 2045.
By 2029 from a 2022 baseline, Roche commits to reduce absolute Scope 1 and 2 GHG emissions by 70; reduce absolute Scope 3 GHG emissions from fuel and energy, waste from company operations and business travel by 22.5%; and reduce absolute Scope 3 GHG emissions from use of sold products and end of life of sold products by 22.5%. The company also commits that 70% of its suppliers by emissions covering Scope 3 purchased goods and services, capital goods and upstream transportation and distribution will have science-based targets.
For its long-term target Roche commits to reduce absolute Scope 1, 2 and 3 GHG emissions by 90% to achieve net zero by 2045 from a 2022 baseline.
“It is well understood that planetary health and human health are interconnected. The SBTi validation underscores our deep commitment to addressing climate change and enabling a sustainable future for all. We are prioritising significant reductions across our entire value chain to achieve these targets. Regarding Scope 1 and 2 emissions, we are even going beyond the SBTi targets, by striving for absolute zero by 2050. We are the only ones going for absolute zero in our industry, which makes me extremely proud,” said Silke Hörnstein, Head of Corporate Strategy and Sustainability, in a statement.
Read These Related Articles:
Share this valuable information with your colleagues using the buttons below:
« Back to NewsStay Up-To-Date
